Basic information Safety Supplier Related

Glycidyl Stearate-d5

Basic information Safety Supplier Related

Glycidyl Stearate-d5 Basic information

Product Name:
Glycidyl Stearate-d5
Synonyms:
  • OUQGOXCIUOCDNN-UITAJUKKSA-N
  • [2H5]-Glycidyl Stearate
  • Glycidyl stearate-d5, Gly-S-d5
  • D5-Glycidyl Ssearate
  • Glycidyl Stearate-d5 (1.0 mg/mL in Toluene)
  • Glycidyl Stearate-d5 (1.0 mg/mL in isopropanol) Discontinued. Please see KIT8406
  • Dideuterio-(2,3,3-trideuteriooxiran-2-yl)methyl] octadecanoate
  • (Oxiran-2-yl-d3)methyl-d2 stearate
CAS:
1346598-19-3
MF:
C21H40O3
MW:
340.55
Mol File:
1346598-19-3.mol
More
Less

Glycidyl Stearate-d5 Chemical Properties

storage temp. 
Storage temp. 2-8°C
solubility 
Chloroform: soluble; Methanol: soluble
form 
A solid
color 
White to off-white
More
Less

Glycidyl Stearate-d5 Usage And Synthesis

Description

Stearic acid glycidyl ester-d5 is intended for use as an internal standard for the quantification of stearic acid glycidyl ester by GC- or LC-MS. Stearic acid glycidyl ester is an esterized form of stearic acid (Item No. 10011298) containing a glycidyl group. It induces the formation of subcutaneous sarcomas and pulmonary tumors in mice when administered at a doses of 0.005-10 mg/animal and induces the formation of breast carcinomas at 0.1 mg/animal. However, serum levels of stearic acid glycidyl ester are decreased in patients with prostate cancer compared to patients with benign prostatic hyperplasia and are negatively correlated with total cholesterol, LDL, and apolipoprotein B (ApoB) levels.

Uses

Labelled Glycidyl Stearate (G615985). Acid-hydrolyzable ester derivatives as low calorie fat mimetics. It is used in frying oil, margarine, ice cream, milk substitutes and bakery. Carcinogenic substance.

References

1. Swern, D., Wieder, R., McDonough, M., et al. Investigation of fatty acids and derivatives for carcinogenic activity. Cancer Res. 30(4), 1037-1046 (1970).
2. Xu, B., Chen, Y., Chen, X., et al. Metabolomics profiling discriminates prostate cancer from benign prostatic hyperplasia within the prostate-specific antigen gray zone. Front. Oncol. 11, 730638 (2021). DOI:10.3389/fonc.2021.730638.

Glycidyl Stearate-d5 Supplier

Yichang Zhongyitai Trading Co., Ltd.
Tel
0717-6449896 13886658719
Email
root@zhongyitai.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
ShangHai Anpel Co, Ltd.
Tel
18501792038 18502138905
Email
shanpel@anpel.com.cn
Energy Chemical
Tel
021-58432009 400-005-6266
Email
marketing1@energy-chemical.com
Bide Pharmatech Ltd.
Tel
400-1647117 13681763483
Email
product02@bidepharm.com
More
Less